回复@流浪的锤子01: (C) SAFE HARBOR.—The term ‘‘biotechnology equipment or services produced or provided by a biotechnology company of concern’’ shall not be construed to refer to any bio technology equipment or services that were formerly, but are no longer, produced or provided by biotechnology companies of concern. 我理解是不追溯历史，以前药明参与研发不要紧，只要现在提供给他们的不由药明生产就可以。//@流浪的锤子01:回复@flyiiiing:那么，默沙东研制的某款药，在研发时并不知道是否要供给给退伍军人事业部，于是找了药明，等药物出来了，就不能再给退伍军人事业部。
那按这个逻辑，只要受限的机构足够有市场，理论上药企在研发时就不敢找药明。
老美真是阴啊，虽然没限制医保，但让药企在一开始就作出站队。$药明生物(02269)$